β‐Glucuronidase‐Expressing Lactobacillus reuteri Triggers Irinotecan Enterotoxicity Through Depleting the Regenerative Epithelial Stem/Progenitor Pool
Abstract Irinotecan (CPT11)‐induced diarrhea affects 80–90% of cancer patients due to β‐glucuronidase (GUS) converting 7‐ethyl‐10‐hydroxycamptothecin glucuronide (SN38G) to 7‐ethyl‐10‐hydroxycamptothecin (SN38). It remains unclear whether SN38 impacts the homeostasis between gut microbiota and mucos...
Saved in:
Main Authors: | Bei Yue, Ruiyang Gao, Ling Zhao, Donghui Liu, Cheng Lv, Ziyi Wang, Fangbin Ai, Beibei Zhang, Zhilun Yu, Xiaolong Geng, Hao Wang, Kang Wang, Kaixian Chen, Chenghai Liu, Zhengtao Wang, Wei Dou |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2025-07-01
|
Series: | Advanced Science |
Subjects: | |
Online Access: | https://doi.org/10.1002/advs.202411052 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
BEVACIZUMAB IN COMBINATION WITH IRINOTECAN IN THE TREATMENT OF RECURRENT GLIOBLASTOMAS
by: D. R. Naskhletashvili, et al.
Published: (2015-04-01) -
Development and Characterization of Optimized Drug-Loaded Niosomes for Delivery of 5-FU and Irinotecan
by: Kafilat O. Agbaje, et al.
Published: (2025-07-01) -
Development of pilot technology for liposomal irinotecan production
by: O. V. Stadnichenko, et al.
Published: (2018-08-01) -
Complete response to bevacizumab plus irinotecan in patients with rapidly progressive GBM: Cases report and literature review
by: Oguz Ozel, et al.
Published: (2016-08-01) -
Lactobacillus reuteri E9 Regulates Sleep Disorders Through Its Metabolite GABA
by: Yongcheng Jiang, et al.
Published: (2025-06-01)